A. Goris et al., Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis inEurope: Effect of population structure on association with disease, J INTERF CY, 19(9), 1999, pp. 1037-1046
An intronic dinucleotide polymorphism in the IFN-gamma gene (IFNG) was used
as a marker for testing association with multiple sclerosis FIS). Disease
association was analyzed in case-control sets sampled from four geographica
lly separate European populations (Germany, Northern Italy, Sardinia, and S
weden). Only in the Swedish was a weak disease association of the IFNG alle
le pattern found, mainly due to a higher frequency of IFNG allele I1 in MS
patients. Na evidence for association was found in the German or Northern I
talian populations. These results contrast with the situation in Sardinia,
We have recently reported transmission disequilibrium of IFNG allele I2 in
Sardinian MS siblings not carrying the predisposing DRB1*03 or *04 alleles
(Ann, Neurol, 44, 841-842, 1998), Further analysis now shows that I2 is sig
nificantly more often transmitted to DRB1*03(-)/*04(-) males, than to DRB1*
03(-)/*04(-). females. The odds ratio (OR) for IFNG-associated susceptibili
ty to MS in the total Sardinian DRB1*03(-)/*04(-) group was 1.88 for I2 het
erozygotes but amounted to 8.235 for I2 homozygotes, suggestive of a recess
ive mode of inheritance. Score test-based statistics pointed to an I2 allel
e dosage effect acting in susceptibility. Comparison of the IFNG allele fre
quencies in seven European populations (Northern Finnish, Southern Finnish,
Swedish, Danish, German, Italian, and Sardinian) revealed a highly differe
nt distribution pattern. We introduced latitude as a score variable in orde
r to test for trend in binomial proportions, This test statistic showed tha
t for both most common alleles, I1 and I2 (compiled allele frequency about
85%), a significant opposite north-to-south trend is seen throughout Europe
. This effect is primarily due to the extreme values found in the outlier p
opulations of Finland and Sardinia. Our findings are discussed with respect
to recent literature pertinent to the role of the IFNG chromosome region i
n autoimmune diseases.